SCHEMBL7492402

SCHEMBL7492402

FC(F)(F)COCCn1c(NC2CCNCC2)nc2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 11/20 0.59
NR4A2 P43354 2/20 0.59
SSTR5 P35346 4/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
MEN1 O00255 1/20 0.41
MLNR O43193 1/20 0.41
CACNA1F O60840 1/20 0.41
EED O75530 1/20 0.41
USP2 O75604 1/20 0.41
ABCB11 O95342 1/20 0.41
EGFR P00533 1/20 0.41
LMNA P02545 1/20 0.41
HLA-A P04439 1/20 0.41
ERBB2 P04626 1/20 0.41
TP53 P04637 1/20 0.41
LCK P06239 1/20 0.41
FYN P06241 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7985497 0.86 KCNH2 (0.60) KCNH2NR4A2SSTR5CYP1A2CYP2C19
SCHEMBL6991613 0.86 KCNH2 (0.59) KCNH2NR4A2MEN1CHRM1HRH1
SCHEMBL9536919 0.85 KCNH2 (0.58) KCNH2NR4A2SSTR5MEN1HRH1
SCHEMBL13319057 0.85 KCNH2 (0.63) KCNH2NR4A2SSTR5CYP1A2CYP2C19
SCHEMBL7494343 0.83 KCNH2 (0.67) KCNH2NR4A2SSTR5CYP1A2CYP2C19
SCHEMBL7980989 0.81 KCNH2 (0.58) KCNH2NR4A2SSTR5CYP1A2CYP2C19
SCHEMBL7985049 0.80 KCNH2 (0.65) KCNH2NR4A2SSTR5
Oxalic Acid SCHEMBL10384126 0.78 KCNH2 (0.50) KCNH2NR4A2MEN1LMNAHRH1
Oxalic Acid SCHEMBL10384125 0.78 KCNH2 (0.50) KCNH2NR4A2MEN1LMNAHRH1
SCHEMBL7471446 0.78 HRH1 (0.42) MAPTTACR2TACR1HRH1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888336-B1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL-AMINO)P IPERIDIN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES AVENTIS PHARMA INC (US) 2002-08-07 EP disclosed
US-6211199-B1 HISTAMINE AND TACHYKININ RECEPTOR ANTAGONISTS; ANTIASTHMATICS, ANTIEMETICS; RESPIRATORY SYSTEM DISORDERS, INFLAMMATORY BOWEL DISEASE, CONJUNCTIVITIS AVENTIS PHARMACEUTICALS INC. 2001-04-03 US disclosed
US-5922737-A Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases HOECHST MARION ROUSSEL, INC. (US) 1999-07-13 US disclosed